VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CTS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CTSCTS Corporation
$64.57$1.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCTSFinancials

CTS Corporation (CTS) Financials

30Y historyFree accessUpdated daily

Revenue growth has accelerated to 10.9% as of 2026Q1, supported by a structural expansion in gross margins from 32.9% in 2023Q4 to 38.5% in the most recent quarter.

CTS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue555.85M542.16M515.54M550.55M586.87M512.92M424.19M469M470.1M423.48M396.8M382.31M404.02M409.46M576.92M588.51M552.64M498.98M691.71M685.95M655.61M617.48M531.32M462.99M457.8M577.65M866.52M677.1M370.4M415.2M321.3M
Revenue Growth %7.8%5.16%-6.36%-6.19%14.42%20.92%-9.55%-0.23%11.01%6.72%3.79%-5.37%-1.33%-29.03%-1.97%6.49%10.75%-27.86%0.84%4.63%6.18%16.22%14.76%1.13%-20.75%-33.34%27.98%82.8%-10.79%29.23%7.03%
Cost of Goods Sold340.7M333.43M327.33M362.36M377.25M329.69M284.25M312.28M301.47M282.06M256.36M254.57M272.12M288.11M475.54M478.66M432.73M400.14M554.33M553.05M534.78M497.27M421.56M366.27M366.77M466.36M566.48M441.2M236.6M282.6M221.3M
COGS % of Revenue-61.5%63.49%65.82%64.28%64.28%67.01%66.59%64.13%66.61%64.61%66.59%67.35%70.36%82.43%81.33%78.3%80.19%80.14%80.63%81.57%80.53%79.34%79.11%80.12%80.73%65.37%65.16%63.88%68.06%68.88%
Gross Profit215.15M208.73M188.21M188.19M209.61M183.24M139.94M156.72M168.63M141.42M140.44M127.74M131.9M121.35M101.38M109.85M119.91M98.84M137.37M132.89M120.83M120.21M109.76M96.71M91.03M111.29M300.04M235.9M133.8M132.6M100M
Gross Margin %38.71%38.5%36.51%34.18%35.72%35.72%32.99%33.41%35.87%33.39%35.39%33.41%32.65%29.64%17.57%18.67%21.7%19.81%19.86%19.37%18.43%19.47%20.66%20.89%19.88%19.27%34.63%34.84%36.12%31.94%31.12%
Gross Profit Growth %-10.9%0.01%-10.22%14.4%30.93%-10.7%-7.07%19.25%0.69%9.94%-3.15%8.69%19.7%-7.71%-8.39%21.32%-28.05%3.37%9.98%0.51%9.53%13.49%6.24%-18.21%-62.91%27.19%76.31%0.91%32.6%15.61%
Operating Expenses126.8M123.99M111.67M108.73M115.62M106.45M92.1M96.47M98.77M97.04M84.86M96.59M81.7M93.21M97.3M91.88M90.62M81.27M100.89M97.97M88.93M85.35M82.55M78.33M87.45M119.74M171.41M140.1M84.2M81.3M66.6M
OpEx % of Revenue-22.87%21.66%19.75%19.7%20.75%21.71%20.57%21.01%22.92%21.39%25.26%20.22%22.76%16.87%15.61%16.4%16.29%14.59%14.28%13.56%13.82%15.54%16.92%19.1%20.73%19.78%20.69%22.73%19.58%20.73%
Selling, General & Admin101.08M98.72M88.28M83.82M91.52M82.6M67.78M70.5M73.46M71.9M60.82M59.59M59.14M69.99M76.39M71.89M72.31M67.12M82.59M82.08M70.91M68.25M63.48M56.86M63.34M80.21M94.5M80.9M51.6M51M54.1M
SG&A % of Revenue-18.21%17.12%15.22%15.59%16.1%15.98%15.03%15.63%16.98%15.33%15.59%14.64%17.09%13.24%12.22%13.08%13.45%11.94%11.97%10.82%11.05%11.95%12.28%13.84%13.89%10.91%11.95%13.93%12.28%16.84%
Research & Development25.71M25.27M23.39M24.92M24.1M23.86M24.32M25.97M25.3M25.15M24.04M22.46M22.56M23.22M20.92M19.99M18.31M14.15M18.31M15.9M15.87M17.09M19.06M21.48M24.12M32.76M32.58M25.3M13.4M13.3M0
R&D % of Revenue-4.66%4.54%4.53%4.11%4.65%5.73%5.54%5.38%5.94%6.06%5.88%5.58%5.67%3.63%3.4%3.31%2.84%2.65%2.32%2.42%2.77%3.59%4.64%5.27%5.67%3.76%3.74%3.62%3.2%-
Other Operating Expenses0000000000014.54M000000002.14M00006.76M44.33M33.9M19.2M17M12.5M
Operating Income88.36M84.74M76.53M79.46M93.99M76.78M47.85M60.25M69.87M44.37M55.58M31.15M50.2M28.14M4.08M17.97M29.29M17.57M36.48M34.92M31.9M34.87M27.21M13.82M-14.77M-48.49M128.63M95.8M49.6M51.3M33.4M
Operating Margin %15.9%15.63%14.85%14.43%16.02%14.97%11.28%12.85%14.86%10.48%14.01%8.15%12.42%6.87%0.71%3.05%5.3%3.52%5.27%5.09%4.87%5.65%5.12%2.98%-3.23%-8.39%14.84%14.15%13.39%12.36%10.4%
Operating Income Growth %-10.72%-3.68%-15.46%22.42%60.48%-20.58%-13.77%57.46%-20.17%78.42%-37.94%78.38%590.09%-77.31%-38.65%66.72%-51.84%4.47%9.45%-8.5%28.15%96.93%193.55%69.54%-137.7%34.27%93.15%-3.31%53.59%21.9%
EBITDA123.21M119.28M107.46M108.17M123.75M103.71M74.52M84.87M92.38M65.05M74.57M47.41M67.17M45.44M23.69M35.52M46.85M37.1M60.66M57.74M56.8M61.93M53.29M47.42M28.6M3.19M172.96M129.7M68.8M68.3M45.9M
EBITDA Margin %22.17%22%20.84%19.65%21.09%20.22%17.57%18.1%19.65%15.36%18.79%12.4%16.63%11.1%4.11%6.04%8.48%7.43%8.77%8.42%8.66%10.03%10.03%10.24%6.25%0.55%19.96%19.16%18.57%16.45%14.29%
EBITDA Growth %11.78%11%-0.66%-12.59%19.32%39.18%-12.2%-8.13%42.03%-12.77%57.3%-29.42%47.81%91.8%-33.29%-24.19%26.29%-38.84%5.06%1.65%-8.28%16.21%12.38%65.78%798.08%-98.16%33.35%88.52%0.73%48.8%17.39%
D&A (Non-Cash Add-back)34.85M34.54M30.92M28.71M29.75M26.93M26.67M24.62M22.51M20.67M18.99M16.25M16.97M17.3M19.61M17.55M17.57M19.53M24.18M22.82M24.9M27.06M26.08M33.6M43.37M51.67M44.33M33.9M19.2M17M12.5M
EBIT88.36M84.74M77.25M80.79M83.47M-59.51M48.32M53.41M60.61M43.63M61.88M15.66M42.16M21M29.51M28.46M29.1M-18.54M33.11M35.58M34.32M38.9M31.45M18.38M3.57M-8.45M128.63M95.8M49.6M49.2M33.4M
Net Interest Income-2.69M-3.37M46K1.29M-866K-1.27M-2.23M-911K-259K-2.06M-2.4M445K460K-1.36M-849K-851K-689K-1.72M-4.77M-1.05M00000000000
Interest Income2.17M2.13M4.28M4.63M1.33M840K1.05M1.74M1.83M1.28M1.3M3.07M2.79M1.9M1.72M1.26M001.42M2.05M00000000000
Interest Expense4.86M5.5M4.24M3.33M2.19M2.11M3.27M2.65M2.08M3.34M3.7M2.63M2.33M3.26M2.57M862K689K1.72M3.81M3.1M00000000000
Other Income/Expense965K-971K-5.31M-4.31M-13.26M-137.66M-2.37M-9.98M-11.77M-4.12M1.67M-18.89M-10.85M-10.08M22.86M8.37M-1.26M-37.98M-7.18M-2.44M-1.24M-1.87M-1.29M-7.57M-9.03M-12M-11.5M-21.7M-100K-13.5M200K
Pretax Income89.32M83.77M71.22M75.15M80.74M-60.88M45.48M50.27M58.1M40.25M57.24M12.26M39.35M18.06M26.94M26.34M28.03M-20.41M29.3M32.48M30.67M33M25.92M6.25M-23.8M-60.49M117.13M74.1M49.5M35.1M33.6M
Pretax Margin %16.07%15.45%13.82%13.65%13.76%-11.87%10.72%10.72%12.36%9.51%14.43%3.21%9.74%4.41%4.67%4.48%5.07%-4.09%4.24%4.73%4.68%5.34%4.88%1.35%-5.2%-10.47%13.52%10.94%13.36%8.45%10.46%
Income Tax20.18M18.45M13.11M14.62M21.16M-19.01M10.79M14.12M11.57M25.8M22.86M5.31M12.83M16.07M6.61M5.37M5.99M13.64M-591K7.06M6.47M13.17M5.96M-6.33M-5.95M-15.12M32.8M22.6M15.4M12.3M12.4M
Effective Tax Rate %22.59%22.03%18.41%19.45%26.21%31.23%23.73%28.09%19.91%64.11%39.94%43.28%32.6%88.94%24.53%20.39%21.37%-66.8%-2.02%21.75%21.1%39.91%23%-101.26%25%24.99%28%30.5%31.11%35.04%36.9%
Net Income69.15M65.32M58.11M60.53M59.58M-41.87M34.69M36.15M46.53M14.45M34.38M6.95M26.52M1.22M20.33M20.97M22.04M-34.05M29.89M25.41M24.2M20.76M19.96M12.57M-17.85M-45.38M83.8M51.5M37.5M22.8M21.2M
Net Margin %12.44%12.05%11.27%10.99%10.15%-8.16%8.18%7.71%9.9%3.41%8.66%1.82%6.56%0.3%3.52%3.56%3.99%-6.82%4.32%3.7%3.69%3.36%3.76%2.72%-3.9%-7.85%9.67%7.61%10.12%5.49%6.6%
Net Income Growth %14.55%12.39%-3.99%1.61%242.3%-220.7%-4.04%-22.32%222.07%-57.98%394.39%-73.78%2075.72%-94%-3.02%-4.86%164.72%-213.93%17.61%5.02%16.58%4.01%58.7%170.45%60.66%-154.15%62.72%37.33%64.47%7.55%23.26%
Net Income (Continuing)69.15M65.32M58.11M60.53M59.58M-41.87M34.69M36.15M46.53M14.45M34.38M6.95M26.52M2M20.33M20.97M22.04M-34.05M29.89M25.41M24.2M20.76M19.96M12.57M-17.85M-45.38M84.33M51.5M34.1M23.2M21.2M
Discontinued Operations0000000000000-778K00000000000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)2.382.191.891.921.85-1.301.061.091.390.431.030.210.78-0.110.590.600.63-1.010.810.660.630.530.530.36-0.54-1.612.921.801.280.710.67
EPS Growth %18.78%15.87%-1.56%3.78%242.31%-222.64%-2.75%-21.58%223.26%-58.25%390.48%-73.08%809.09%-118.64%-1.67%-4.76%162.38%-224.69%22.73%4.76%18.87%0%47.22%166.67%66.46%-155.14%62.22%40.63%80.28%5.97%21.82%
EPS (Basic)-2.211.911.931.86-1.301.071.111.410.441.050.210.79-0.120.600.610.65-1.010.830.720.680.570.560.36-0.54-1.613.031.871.340.730.68
Diluted Shares Outstanding29M29.81M30.72M31.58M32.24M32.33M32.58M33.1M33.57M33.42M33.25M33.48M34.13M34.25M34.52M35.01M34.85M33.82M37.86M39.97M38.41M39.16M37.65M34.93M33.06M28.18M28.7M28.61M29.3M32.11M31.64M
Basic Shares Outstanding28.69M29.51M30.41M31.36M31.97M32.33M32.32M32.7M33.02M32.89M32.73M32.96M33.62M33.6M33.92M34.32M34.09M33.82M33.73M35.5M35.58M36.41M35.64M34.93M33.06M28.18M27.66M27.54M27.99M31.23M31.18M
Dividend Payout Ratio-7.27%8.41%8.33%8.61%-14.93%14.49%11.36%36.41%15.22%76.09%20.26%399.84%23.41%19.65%18.55%-13.59%16.84%17.8%20.92%22.73%32.5%--3.98%6.41%9.07%16.67%16.04%

Key Metrics

Growth RegimeAccelerating
ProfitabilityModerate
Balance SheetFortress
Cash FlowRobust
Top Statement Risk

Automotive production cyclicality

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Momentum Accelerating

According to recent quarterly filings, CTS has successfully transitioned from a period of negative year-over-year growth in early 2024 to a 10.9% revenue expansion by 2026Q1, suggesting that the company's strategic pivot toward high-margin medical and industrial applications is beginning to gain meaningful traction.

The shift from double-digit revenue declines in early 2024 to consistent positive growth indicates that the company is successfully diversifying away from its legacy automotive exposure. Investors should monitor whether this acceleration is sustainable or if it remains sensitive to the timing of large-scale industrial design wins.

Structural Gross Margin Expansion Observed

As reported in financial statements, CTS has demonstrated a clear upward trend in gross margins, which climbed from 32.9% in 2023Q4 to 38.5% in 2026Q1, reflecting improved pricing power and a more favorable product mix within its specialized piezoelectric and connectivity component segments.

This margin expansion appears to be a direct result of the company's focus on proprietary material science rather than commoditized hardware. The ability to maintain these levels despite raw material price volatility suggests that the company's specialized offerings provide a degree of insulation from standard manufacturing cost pressures.

Operating Leverage Remains Disciplined

Based on the provided income statement data, CTS has maintained operating margins between 12.3% and 17.4% over the last ten quarters, indicating that management has successfully scaled overhead costs in alignment with revenue growth while avoiding excessive expansion of the SG&A expense base.

The company's ability to keep operating expenses relatively stable while revenue trends upward suggests a high degree of operational discipline. This efficiency implies that incremental revenue gains are likely to flow more effectively to the bottom line, provided that manufacturing utilization rates remain optimized.

Earnings Quality Impacted by SBC

Analysis of recent filings reveals that stock-based compensation has trended upward to $2.0M in 2026Q1, which warrants careful scrutiny as it represents a non-cash expense that may slightly dilute the quality of reported net income and EPS growth figures for long-term shareholders.

While the company shows strong EPS growth, the rising trend in stock-based compensation suggests that investors should adjust their valuation models to account for the impact of equity-based incentives. This trend may indicate a shift in compensation strategy that could affect future earnings per share if not offset by operational gains.

Cyclical Risks to Margin Stability

Despite recent improvements, the company's reliance on automotive-linked design wins, as noted in historical performance data, suggests that any significant downturn in global vehicle production could lead to rapid margin compression due to the high fixed-cost nature of its specialized ceramic manufacturing facilities.

Short-term investors should remain cautious regarding the company's sensitivity to automotive production cycles, which could quickly reverse the recent margin gains. The potential for underutilization of manufacturing capacity remains a primary risk factor that could undermine the current narrative of secular growth in the medical and aerospace segments.

CTS — Frequently Asked Questions

Quick answers to the most common questions about buying CTS stock.

What was CTS Corporation's (CTS) revenue in 2025?

For fiscal year 2025, CTS Corporation (CTS) reported total revenue of $542.2M. This represents a 68.7% increase compared to $321.3M in 1996.

Is CTS Corporation (CTS) profitable?

CTS Corporation (CTS) is profitable, generating $65.3M in net income for the fiscal year ending 2025 with a net profit margin of 12.0%.

What is CTS Corporation's operating profit margin?

CTS Corporation (CTS) reported an operating income of $84.7M, resulting in an operating profit margin of 15.6%. This margin reflects the operational efficiency of the business before interest and taxes.

What is CTS Corporation's gross profit and gross margin?

CTS Corporation (CTS) generated $208.7M in gross profit for the year, representing a gross profit margin of 38.5%. This demonstrates the company's core pricing power and production efficiency.